“Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways 23, no. 1 (February 2, 2022). Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1516.